There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
See the full list of benefits that ESMO members enjoy including access to OncologyPRO, subscription to Annals of Oncology and reduced meeting registration fees
A unique networking resource for ESMO members wishing to contact one another.
EMUC14 in Lisbon, Portugal? Onsite registration is possible. Come and visit our booth to find out about our latest membership news and benefits!
We have a network of National and Regional Representatives who act as ambassadors of ESMO’s mission in their respective country or region
The member panel gives feedback on ESMO products and services through the completion of regular online surveys. Would you like to contribute?
ESO-ESMO Advanced Breast Cancer • Primary Breast Cancer • BRCA in Breast Cancer
Cancers of Unknown Primary Site
High-Grade Malignant Glioma
Adrenal cancer • Thyroid cancer
Anal Cancer • Metastatic Colorectal Cancer • Oesophageal Cancer • Gastric Cancer • Early Colon Cancer • Familial Risk Colorectal Cancer • Rectal Cancer • Pancreatic Adenocarcinoma • Hepatocellular Carcinoma • Biliary Cancer
Bladder Cancer • Renal Cell Carcinoma • Prostate Cancer • Penile Carcinoma • Testicular Seminoma and Non-Seminoma
Endometrial Cancer • Gestational Trophoblastic-Disease • Newly-Diagnosed and Relapsed Epithelial Ovarian Carcinoma • Non-Epithelial Ovarian Cancer
Mantle Cell Lymphoma • Follicular Lymphoma • Hodgkin's Lymphoma • Primary Cutaneous Lymphoma • Multiple Myeloma • AML in Adult Patients • Waldenstrom's Macroglobulinaemia • Gastric Marginal Zone Lymphoma of MALT Type • CML • Diffuse Large B Cell Lymphoma • CLL
Nasopharyngeal Cancer • Squamous-Cell Carcinoma of the Head and Neck
Metastatic Non-Small-Cell Lung Cancer • Early-Stage and Locally Advanced (non metastatic) Non-Small-Cell Lung Cancer • Small-Cell Lung Cancer • Malignant Pleural Mesothelioma
Neuroendocrine Bronchial and Thymic Tumours • Neuroendocrine Gastroenteropancreatic Tumours
Soft Tissue and Visceral Sarcomas • Bone Sarcomas • Gastrointestinal Stromal Tumours
Refractory Symptoms • Advanced Care Planning • Bone Health • Cancer, Pregnancy and Fertility • Chemotherapy Extravasation • Cardiovascular Toxicity • Cancer Pain • Venous Thromboembolism • Mucositis • Erythropoiesis Stimulating Agents in the Treatment of Anaemia • Prevention of Chemotherapy and Radiotherapy Induced Nausea and Vomiting • Febrile Neutropenia • Haematopoietic Growth Factors
Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients
All webcasts and presentations from #ESMO14 are now online!
Join us in Geneva, Switzerland. 21-22 November 2014
Penang, Malaysia. 23-25 January 2015
Join ESMO, ESTRO and EHNS in Nice, France. 12-14 Feb 2015
Save the date for the symposium: 6 March 2015 in Valencia, Spain
Join us in Barcelona, Spain for Signalling Pathways 2015. 13-14 March 2015
Join EORTC, EANO & ESMO for this conference in Istanbul, Turkey. 27-28 March 2015
European Lung Cancer Conference 2015, Geneva, Switzerland; 15-18 April 2015
Save the date for the IMPAKT 2015 breast cancer conference: 7-9 May 2015
The 2015 ESMO World Congress on Gastrointestinal Cancer will place from 1-4 July 2015 in Barcelona, Spain
Join us for this new course for medical oncologists: 28-30 Aug 2015, Oxford, UK
Save the date for the European Cancer Congess 2015: Vienna, Austria, 25-29 September 2015
The first ESMO Asia congress will take place in Singapore, 18-21 December 2015
ESMO members under 40: Apply now to join the Preceptorship on Immunotherapy of Cancer taking place in Manchester, UK, 23-24 January 2015. Deadline 23 December 2014
View the complete list of ESMO oncology conferences including partnership, labelled and supported meetings.
The ESMO Events App is our event library app that lists all ESMO conferences
Access information and reports from past ESMO events
Addressing the daily needs of ESMO young oncologists
Invest in your future and the future of cancer care. Learn more about our Oncology Fellowship Programme.
The latest oncology jobs can be found here, including information on how to post a job.
The winners of the 2014 ESMO Awards, were presented during the opening ceremony at ESMO 2014 Congress in Madrid, Spain
The Recommendations are a set of guidelines with for clinical training in medical oncology. The 2010 update is now available in Portuguese.
ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.
The ESMO examination is a valuable assessment tool for practising medical oncologists and an excellent opportunity for medical oncologists in training to assess their knowledge
If you’ve already sat the ESMO exam, then take a look at our CME opportunities.
Discover the results of the ESMO Survey on the challenges faced by female oncologists
An ESMO pre-selected listing of the most recent EU research funding opportunities
Relevant information and tools to guide you through various EU grant application procedures
What`s available in terms of clinical research training and educational events
Clear, relevant information on EU clinical trials and data protection legislation
Useful links to partners and tools for your research projects
General European grant scheme information highlighting the main objectives, available funding and target audiences
Most ESMO Cancer Guides for Patients are now available in Greek. Download your copy now!
Now available in Greek, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.
The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.
Read the reports from the ESMO/EAPC opioid survey and the oncologist/patient communication survey.
An integral part of our mission is to keep patients informed about the latest advances in cancer care.
The ESMO Patient Track encourages communication between patients, families, oncologists and healthcare professionals.
Medical oncology is included among the medical specialities covered by the European Commission Directive 2005/36/EC.
ESMO’s political initiatives aim to promote the profession of medical oncology and keep cancer policy high on the European healthcare agenda.
ESMO position statements and recommendations can be downloaded here.
Rare Cancers Europe is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda.
The objective of this ESMO-led study is to provide European health authorities with data on the availability of licensed anti-neoplastic medicines across Europe
ESMO has endorsed the 'Prague Charter: Relieving suffering' set up by the European Association for Palliative Care (EAPC) & other organisations
ESMO seeks to eradicate cancer at its earliest stages through effective cancer prevention awareness and advocacy campaigns.
Information about the EFPIA Disclosure Code which comes into effect 1 January 2015
Published in 2011 – Ann Oncol 2011; 22 (Suppl 6): vi40-vi44.
Authors: F. Eckel, T. Brunner, S. Jelic